Bromfenac is a nonsteroidal anti-inflammatory drug (NSAID) for ophthalmic use. Ophthalmic NSAIDs are becoming a cornerstone for the management of ocular pain and inflammation. Their well-characterized anti-inflammatory activity, analgesic property, and established safety record have also made NSAIDs an important tool for optimizing surgical outcomes. Non-ophthalmic formulations of bromfenac were withdrawn in the US in 1998 due to cases of severe liver toxicity.[L43942,T239]
Synonyms
Bromfenac
[2-Amino-3-(4-bromo-benzoyl)-phenyl]-acetic acid
Bromfenaco
Bromfenacum
Bromfenac sodium
2-amino-3-(4-bromobenzoyl)benzeneacetic acid
Brand Names
Pred Phos-Gati-Brom
Bromfenac Sodium
Prolensa
Yellox
Bromfenac 0.075%
Bromfenac Ophthalmic Solution, 0.09%
Bromfenac Ophthalmic Solution 0.09%
Pred Phos - Brom
Auro-bromfenac
Bromfenac Ophthalmic Solution, 0.07%
Bromfenac Ophthalmic Solution
Pred-Brom
Strenza Plus
Xibrom
Pred-Gati-Brom
Bromsite 0.075%
Bromfenac
Bromday
Apo-bromfenac
Eugia-bromfenac
Indication
For the treatment of postoperative inflammation in patients who have undergone cataract extraction.
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison
T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS.
Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682